Improved Wireless, Transcutaneous Power Transmission for In Vivo Applications von O'Handley, R.C., Huang, J.K., Bono, D.C., Simon, J.

Volltext

Development of Solid State Photomultiplier-Based Electron Imaging Devices von Barbi, N.C., Mott, R.B., Bono, D.C.

Volltext

ELECTROSTATIC LENS von M. FISBHEIN, D.C. BONO, K.J. HARTE

Volltext bestellen

Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol von Sydes, M.R., Spears, M.R., Mason, M.D., Clarke, N.W., Dearnaley, D.P., de Bono, J.S., Attard, G., Chowdhury, S., Cross, W., Gillessen, S., Malik, Z.I., Jones, R., Parker, C.C., Ritchie, A.W.S., Russell, J.M., Millman, R., Matheson, D., Amos, C., Gilson, C., Birtle, A., Brock, S., Capaldi, L., Chakraborti, P., Choudhury, A., Evans, L., Ford, D., Gale, J., Gibbs, S., Gilbert, D.C., Hughes, R., McLaren, D., Lester, J.F., Nikapota, A., O’Sullivan, J., Parikh, O., Peedell, C., Protheroe, A., Rudman, S.M., Shaffer, R., Sheehan, D., Simms, M., Srihari, N., Strebel, R., Sundar, S., Tolan, S., Tsang, D., Varughese, M., Wagstaff, J., Parmar, M.K.B., James, N.D.

Volltext

Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancer von Basu, B., Krebs, M.G., Sundar, R., Wilson, R.H., Spicer, J., Jones, R., Brada, M., Talbot, D.C., Steele, N., Ingles Garces, A.H., Brugger, W., Harrington, E.A., Evans, J., Hall, E., Tovey, H., de Oliveira, F.M., Carreira, S., Swales, K., Ruddle, R., Raynaud, F.I., Purchase, B., Dawes, J.C., Parmar, M., Turner, A.J., Tunariu, N., Banerjee, S., de Bono, J.S., Banerji, U.

Volltext

Cabozantinib (XL184) At 40 Mg in Patients with Metastatic Castration Resistant Prostate Cancer (MCRPC): Results of a Phase 2 Non-Randomized Expansion Cohort (NRE) von de Bono, J.S., Smith, M.R., Rathkopf, D., Corn, P.G., Mukherji, D., Harzstark, A.L., Sartor, O.A., Smith, D.C., Tunariu, N., Sweeney, C.

Volltext

Use of Positron Emission Tomography in Pharmacokinetic Studies to Investigate Therapeutic Advantage in a Phase I Study of 120-Hour Intravenous Infusion XR5000 von Propper, D J, de Bono, J, Saleem, A, Ellard, S, Flanagan, E, Paul, J, Ganesan, T S, Talbot, D C, Aboagye, E O, Price, P, Harris, A L, Twelves, C

Volltext